Niclas Adler
President chez Indonesia International Institute For Life Sciences
Relations actives
Nom | Sexe | Age | Sociétés liées | Collaboration |
---|---|---|---|---|
Graham Eric Fagg | M | 73 |
Akinion Pharmaceuticals AB
Akinion Pharmaceuticals AB Pharmaceuticals: MajorHealth Technology Akinion Pharmaceuticals AB operates as a holding company that focuses on the development of pharmaceutical for the treatment of acute myeloid leukemia. It develops, markets, and sells a product based on Biovitrum’s anti leukemia kinase inhibitor research. It is a drug development that manufactures a lead candidate drug, AKN-028, which is a small molecule kinase inhibitor. The company was founded by Vendela Parrow in 2009 and is headquartered in Solna, Sweden. | - |
Peter Madden | M | 82 |
Babson College
| - |
Jeffery Perry | M | 58 |
Babson College
| - |
Terje Kalland | M | 73 |
Akinion Pharmaceuticals AB
Akinion Pharmaceuticals AB Pharmaceuticals: MajorHealth Technology Akinion Pharmaceuticals AB operates as a holding company that focuses on the development of pharmaceutical for the treatment of acute myeloid leukemia. It develops, markets, and sells a product based on Biovitrum’s anti leukemia kinase inhibitor research. It is a drug development that manufactures a lead candidate drug, AKN-028, which is a small molecule kinase inhibitor. The company was founded by Vendela Parrow in 2009 and is headquartered in Solna, Sweden. | - |
Jonathan Carson | M | - |
Babson College
| - |
Karin Birgitta Margareta Ståhl | F | 53 |
Akinion Pharmaceuticals AB
Akinion Pharmaceuticals AB Pharmaceuticals: MajorHealth Technology Akinion Pharmaceuticals AB operates as a holding company that focuses on the development of pharmaceutical for the treatment of acute myeloid leukemia. It develops, markets, and sells a product based on Biovitrum’s anti leukemia kinase inhibitor research. It is a drug development that manufactures a lead candidate drug, AKN-028, which is a small molecule kinase inhibitor. The company was founded by Vendela Parrow in 2009 and is headquartered in Solna, Sweden. | - |
Stephen Spinelli | M | 69 |
Babson College
| 31 ans |
Thomas H. Davenport | M | - |
Babson College
| - |
Kristina Carlson | F | - |
Akinion Pharmaceuticals AB
Akinion Pharmaceuticals AB Pharmaceuticals: MajorHealth Technology Akinion Pharmaceuticals AB operates as a holding company that focuses on the development of pharmaceutical for the treatment of acute myeloid leukemia. It develops, markets, and sells a product based on Biovitrum’s anti leukemia kinase inhibitor research. It is a drug development that manufactures a lead candidate drug, AKN-028, which is a small molecule kinase inhibitor. The company was founded by Vendela Parrow in 2009 and is headquartered in Solna, Sweden. | - |
Richard A. Spillane | M | 73 |
Babson College
| 16 ans |
Shikhar Neelkamal Malhotra | M | 41 |
Babson College
| - |
Joe Nedder | M | - |
Babson College
| - |
Jean-Pierre Jeannet | M | 78 |
Babson College
| 50 ans |
Rajendra S. Sisodia | M | 66 |
Babson College
| 11 ans |
Curt Mikael von Euler-Chelpin | M | 71 |
Akinion Pharmaceuticals AB
Akinion Pharmaceuticals AB Pharmaceuticals: MajorHealth Technology Akinion Pharmaceuticals AB operates as a holding company that focuses on the development of pharmaceutical for the treatment of acute myeloid leukemia. It develops, markets, and sells a product based on Biovitrum’s anti leukemia kinase inhibitor research. It is a drug development that manufactures a lead candidate drug, AKN-028, which is a small molecule kinase inhibitor. The company was founded by Vendela Parrow in 2009 and is headquartered in Solna, Sweden. | - |
Linda Kanner | F | - |
Babson College
| - |
Carl Stefan Fraenkel | M | 52 |
Akinion Pharmaceuticals AB
Akinion Pharmaceuticals AB Pharmaceuticals: MajorHealth Technology Akinion Pharmaceuticals AB operates as a holding company that focuses on the development of pharmaceutical for the treatment of acute myeloid leukemia. It develops, markets, and sells a product based on Biovitrum’s anti leukemia kinase inhibitor research. It is a drug development that manufactures a lead candidate drug, AKN-028, which is a small molecule kinase inhibitor. The company was founded by Vendela Parrow in 2009 and is headquartered in Solna, Sweden. | - |
Ninus Caram-Lelham | M | - |
Akinion Pharmaceuticals AB
Akinion Pharmaceuticals AB Pharmaceuticals: MajorHealth Technology Akinion Pharmaceuticals AB operates as a holding company that focuses on the development of pharmaceutical for the treatment of acute myeloid leukemia. It develops, markets, and sells a product based on Biovitrum’s anti leukemia kinase inhibitor research. It is a drug development that manufactures a lead candidate drug, AKN-028, which is a small molecule kinase inhibitor. The company was founded by Vendela Parrow in 2009 and is headquartered in Solna, Sweden. | - |
Anirudh Dhebar | M | 72 |
Babson College
| 27 ans |
Robert Evan Weissman | M | 82 |
Babson College
| - |
Carl Jonas Stefan Ståhlberg | M | 49 |
Akinion Pharmaceuticals AB
Akinion Pharmaceuticals AB Pharmaceuticals: MajorHealth Technology Akinion Pharmaceuticals AB operates as a holding company that focuses on the development of pharmaceutical for the treatment of acute myeloid leukemia. It develops, markets, and sells a product based on Biovitrum’s anti leukemia kinase inhibitor research. It is a drug development that manufactures a lead candidate drug, AKN-028, which is a small molecule kinase inhibitor. The company was founded by Vendela Parrow in 2009 and is headquartered in Solna, Sweden. | - |
Paul Gass | M | - |
Babson College
| - |
Pete Robinson | M | - |
Babson College
| 8 ans |
Angelique Aryanto | F | 53 |
Indonesia International Institute For Life Sciences
Indonesia International Institute For Life Sciences Other Consumer ServicesConsumer Services Indonesia International Institute for Life Sciences (i3l) is a premium life sciences higher education and research institute located in Jakarta, Indonesia. The institute offers ten undergraduate programs, including biomedicine, biotechnology, food science and nutrition, food technology, and pharmacy. The School of Life Sciences at i3l offers undergraduate programs in these fields. The Food Technology program aims to ensure safe manufacture, packaging, and distribution of food, while the Food Science and Nutrition program focuses on the role of food in maintaining future health. The Pharmacy program covers drug discovery, development, clinical trials, drug delivery, drug management, and patient counseling. The institute collaborates with other institutions, including the Business & Hotel Management School in Switzerland, to offer pathway programs. | - |
Agnieszka Kuzniarski | F | - |
Babson College
| - |
Jorge Padron | M | - |
Babson College
| - |
Markus Krautli | M | - |
Babson College
| - |
Raymond Kassin | M | - |
Babson College
| - |
Vicente Carvajal | M | - |
Babson College
| - |
Maria Klockare | F | - |
Akinion Pharmaceuticals AB
Akinion Pharmaceuticals AB Pharmaceuticals: MajorHealth Technology Akinion Pharmaceuticals AB operates as a holding company that focuses on the development of pharmaceutical for the treatment of acute myeloid leukemia. It develops, markets, and sells a product based on Biovitrum’s anti leukemia kinase inhibitor research. It is a drug development that manufactures a lead candidate drug, AKN-028, which is a small molecule kinase inhibitor. The company was founded by Vendela Parrow in 2009 and is headquartered in Solna, Sweden. | - |
Bettina de Longinotti-Buitoni | F | - |
Babson College
| - |
Eduardo Barco | M | - |
Babson College
| - |
Heidi Neck | F | - |
Babson College
| - |
Ben Luippold | M | - |
Babson College
| - |
Michael Chmura | M | - |
Babson College
| - |
John Meewella | M | - |
Akinion Pharmaceuticals AB
Akinion Pharmaceuticals AB Pharmaceuticals: MajorHealth Technology Akinion Pharmaceuticals AB operates as a holding company that focuses on the development of pharmaceutical for the treatment of acute myeloid leukemia. It develops, markets, and sells a product based on Biovitrum’s anti leukemia kinase inhibitor research. It is a drug development that manufactures a lead candidate drug, AKN-028, which is a small molecule kinase inhibitor. The company was founded by Vendela Parrow in 2009 and is headquartered in Solna, Sweden. | - |
Ann-Sofie Sternås | F | - |
Akinion Pharmaceuticals AB
Akinion Pharmaceuticals AB Pharmaceuticals: MajorHealth Technology Akinion Pharmaceuticals AB operates as a holding company that focuses on the development of pharmaceutical for the treatment of acute myeloid leukemia. It develops, markets, and sells a product based on Biovitrum’s anti leukemia kinase inhibitor research. It is a drug development that manufactures a lead candidate drug, AKN-028, which is a small molecule kinase inhibitor. The company was founded by Vendela Parrow in 2009 and is headquartered in Solna, Sweden. | - |
Said Darwazah | M | 67 |
Babson College
| - |
Howard Lorber | M | 75 |
Babson College
| - |
Tim McMahon | M | - |
Babson College
| - |
Gordon D. Prichett | M | 81 |
Babson College
| - |
Myra Maloney Hart | M | 82 |
Babson College
| - |
Ettore Victor Biagioni | M | 66 |
Babson College
| - |
Kay Koplovitz | F | 78 |
Babson College
| - |
Eric Johnson | M | 73 |
Babson College
| 20 ans |
Louis Lavigne | M | 75 |
Babson College
| - |
Craig Benson | M | 69 |
Babson College
| - |
John B. Landry | M | 76 |
Babson College
| - |
Steven I. Bandel | M | 70 |
Babson College
| 8 ans |
Joseph Campanelli | M | 67 |
Babson College
| - |
James Herbert | M | 79 |
Babson College
| - |
Octavio Caraballo | M | 80 |
Babson College
| - |
Lawrence Jean Ring | M | 75 |
Babson College
| 24 ans |
Per Gunnar Båtelson | M | 74 |
SCI Innovation AB
| - |
Frank Fischer | M | 82 |
Babson College
| - |
Robert I. Adler | M | - |
Babson College
| - |
Francis P. Jenkins | M | 81 |
Babson College
| - |
Sunil Bharti Mittal | M | 66 |
Babson College
| - |
Lars Abrahmsén | M | 66 |
Akinion Pharmaceuticals AB
Akinion Pharmaceuticals AB Pharmaceuticals: MajorHealth Technology Akinion Pharmaceuticals AB operates as a holding company that focuses on the development of pharmaceutical for the treatment of acute myeloid leukemia. It develops, markets, and sells a product based on Biovitrum’s anti leukemia kinase inhibitor research. It is a drug development that manufactures a lead candidate drug, AKN-028, which is a small molecule kinase inhibitor. The company was founded by Vendela Parrow in 2009 and is headquartered in Solna, Sweden. | - |
Andrónico Mariano Luksic Craig | M | 69 |
Babson College
| - |
Paul Olean | M | - |
Babson College
| - |
William J. Allard | M | - |
Babson College
| - |
James Hays | M | 66 |
Babson College
| - |
Patricia A. Campbell | F | - |
Babson College
| - |
James P. Masciarelli | M | - |
Babson College
| - |
Brad Johnson | M | 62 |
Babson College
| - |
Charles Wadsworth | M | 67 |
Babson College
| - |
Thomas Gilbane | M | 76 |
Babson College
| - |
Asheesh Advani | M | - |
Babson College
| - |
Virginia MacDowell | F | - |
Babson College
| - |
Tjong Budisantoso | M | - |
Indonesia International Institute For Life Sciences
Indonesia International Institute For Life Sciences Other Consumer ServicesConsumer Services Indonesia International Institute for Life Sciences (i3l) is a premium life sciences higher education and research institute located in Jakarta, Indonesia. The institute offers ten undergraduate programs, including biomedicine, biotechnology, food science and nutrition, food technology, and pharmacy. The School of Life Sciences at i3l offers undergraduate programs in these fields. The Food Technology program aims to ensure safe manufacture, packaging, and distribution of food, while the Food Science and Nutrition program focuses on the role of food in maintaining future health. The Pharmacy program covers drug discovery, development, clinical trials, drug delivery, drug management, and patient counseling. The institute collaborates with other institutions, including the Business & Hotel Management School in Switzerland, to offer pathway programs. | 4 ans |
Graphique Relationnel
Relation dans plusieurs entreprises
Statistiques
Pays | Relations | % du total |
---|---|---|
Etats-Unis | 56 | 78,87% |
Suède | 13 | 18,31% |
Indonésie | 2 | 2,82% |
Age des relations
Actives
Passées
Homme
Femme
Administrateurs
Exécutifs
Provenance des relations
- Bourse
- Insiders
- Niclas Adler
- Réseau Personnel